fbpx Skip to main content

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Sept. 21, 2023

Extracardiac uptake occurs in 11% of Tc-99m PYP scintigraphy patients. However, actionable findings are rare, according to a recent study.

Transthyretin cardiac amyloidosis (ATTR-CA) can be diagnosed with the help of technetium-labeled bone-avid radiotracers. Technetium pyrophosphate (Tc-99m PYP) extracardiac uptake in this situation has yet to be thoroughly studied, and its relevance needs to be better understood.
A study published in the Journal of Nuclear Cardiology evaluated the amount of clinically actionable results in patients receiving nuclear scintigraphy by measuring extracardiac Tc-99m PYP uptake.
Study Population
There were 379 total participants in this study. There were 195 males (51%) and 184 females (49%); 306 self-identified as Black (81%), and 120 self-identified as Hispanic (32%). The average age was 73 years, and the mean BMI was 32.8 kg/m2.
Extracardiac Uptake Distribution of Tc-99M PYP
In 42 individuals (11.1%), extracardiac Tc-99m PYP uptake was discovered. Fourteen participants had Tc-99m PYP uptake exclusively in their bones; 21 had uptake only in their kidneys; four had uptake in both their kidneys and bones; two had uptake only in their breasts; and one had uptake only in their thyroid.
Early Tc-99M Pyp Imaging Is Preferable Due to Kidney Clearance
Patients who were imaged 1 hour after Tc-99m PYP administration were more likely to exhibit extracardiac uptake than those who were imaged 3 hours after Tc-99m PYP administration (23.8% vs. 6.2%, respectively; kidneys, in particular; 14.3% vs. 2.2%, respectively; stratified by scan time). The extracardiac uptake rates of those with ATTR-CA (10.5%) and those without ATTR-CA (12%) were not significantly different.
Positive Clinical Findings After the Tc-99M PYP Imaging
Four patients (1.1%) had clinically actionable results, which were treated according to the recommended strategy. One participant with bone uptake was a planned shoulder arthroplasty patient who suffered from severe, chronic pain in both shoulders due to advanced osteoarthritis. Following a dedicated CT of the neck and thyroid ultrasonography, one patient with diffuse, bilateral thyroid uptake was found to have a heterogeneous nodule measuring 2.2 cm in size.
Increased breast radiotracer uptake was considered abnormal and required follow-up imaging to rule out cancer due to the increased risk.
Extracardiac results may emerge with greater scintigraphy use, requiring follow-up, reporting, communication with patients and providers, and care to detect clinically relevant findings while limiting unnecessary testing.


You May Also Like::  Diagnostic Value of Left Atrial Strain Imaging in Cardiac Amyloidosis

Chan, N., Einstein, A. J., Griffin, J. M., Rosenblum, H., Teruya, S., Cuomo, M., De Los Santos, J., DeLuca, A. J., Johnson, L. L., Kinkhabwala, M., Leb, J., Mintz, A., Fine, D., Helmke, S., Muralidhar, V., Pandey, S., Sabogal, N., Saith, S. E., Winburn, M., . . . Maurer, M. S. (2023). Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. Journal of Nuclear Cardiology. https://doi.org/10.1007/s12350-023-03310-7